46 related articles for article (PubMed ID: 38527445)
1. Hereditary alpha-tryptasemia in 101 patients with mast cell activation-related symptomatology including anaphylaxis.
Giannetti MP; Weller E; Bormans C; Novak P; Hamilton MJ; Castells M
Ann Allergy Asthma Immunol; 2021 Jun; 126(6):655-660. PubMed ID: 33465452
[TBL] [Abstract][Full Text] [Related]
2. A randomized double-blind, placebo-controlled study of omalizumab for idiopathic anaphylaxis.
Carter MC; Maric I; Brittain EH; Bai Y; Lumbard K; Bolan H; Cantave D; Scott LM; Metcalfe DD
J Allergy Clin Immunol; 2021 Mar; 147(3):1004-1010.e2. PubMed ID: 33220353
[TBL] [Abstract][Full Text] [Related]
3. The Genetic Basis and Clinical Impact of Hereditary Alpha-Tryptasemia.
Luskin KT; White AA; Lyons JJ
J Allergy Clin Immunol Pract; 2021 Jun; 9(6):2235-2242. PubMed ID: 33744473
[TBL] [Abstract][Full Text] [Related]
4. Use of omalizumab for management of idiopathic anaphylaxis: A systematic review and retrospective case series.
Kaminsky LW; Aukstuolis K; Petroni DH; Al-Shaikhly T
Ann Allergy Asthma Immunol; 2021 Oct; 127(4):481-487. PubMed ID: 34175498
[TBL] [Abstract][Full Text] [Related]
5. Prevention of Anaphylaxis Episodes in Idiopathic Anaphylaxis by Omalizumab.
Košnik M; Zugan L; Rijavec M
Int Arch Allergy Immunol; 2024 Mar; ():1-6. PubMed ID: 38527445
[TBL] [Abstract][Full Text] [Related]
6. Clonal mast cell disorders and hereditary α-tryptasemia as risk factors for anaphylaxis.
Kačar M; Rijavec M; Šelb J; Korošec P
Clin Exp Allergy; 2023 Apr; 53(4):392-404. PubMed ID: 36654513
[TBL] [Abstract][Full Text] [Related]
7. Defining hereditary alpha-tryptasemia as a risk/modifying factor for anaphylaxis: are we there yet?
Couto ML; Silva M; Barbosa MJ; Ferreira F; Fragoso AS; Azenha Rama T
Eur Ann Allergy Clin Immunol; 2023 Jul; 55(4):152-160. PubMed ID: 36927821
[TBL] [Abstract][Full Text] [Related]
8. Incorporating Tryptase Genotyping Into the Workup and Diagnosis of Mast Cell Diseases and Reactions.
Lyons JJ; Greiner G; Hoermann G; Metcalfe DD
J Allergy Clin Immunol Pract; 2022 Aug; 10(8):1964-1973. PubMed ID: 35597543
[TBL] [Abstract][Full Text] [Related]
9. Clinical relevance of inherited genetic differences in human tryptases: Hereditary alpha-tryptasemia and beyond.
Glover SC; Carter MC; Korošec P; Bonadonna P; Schwartz LB; Milner JD; Caughey GH; Metcalfe DD; Lyons JJ
Ann Allergy Asthma Immunol; 2021 Dec; 127(6):638-647. PubMed ID: 34400315
[TBL] [Abstract][Full Text] [Related]
10. Hereditary Alpha-Tryptasemia: a Commonly Inherited Modifier of Anaphylaxis.
Wu R; Lyons JJ
Curr Allergy Asthma Rep; 2021 May; 21(5):33. PubMed ID: 33970354
[TBL] [Abstract][Full Text] [Related]
11. Expanding spectrum of mast cell activation disorders: monoclonal and idiopathic mast cell activation syndromes.
Picard M; Giavina-Bianchi P; Mezzano V; Castells M
Clin Ther; 2013 May; 35(5):548-62. PubMed ID: 23642289
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
